© 2020 MJH Life Sciences and Ophthalmology Times. All rights reserved.
© 2020 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
Washington, DC-Drug companies will be limited to one 30-month stay of a generic drug's entry into the market under new FDA rules introduced by the federal Health and Human Services department.